Showing results (171-180 of 279) with videos related to

Sort By:
Pageof 28
Journal of Clinical Lipidology|December 10, 2013
Lipid control in patients with coronary heart disease treated in primary care or cardiology clinicsDavid Pereg, Avishay Elis, Yoram Neuman, et al.
The Cochrane Database of Systematic Reviews|September 9, 2011
Colony-stimulating factors for prevention and treatment of infectious complications in patients with acute myelogenous leukemiaRonit Gurion, Yulia Belnik-Plitman, Anat Gafter-Gvili, et al.
European Journal of Haematology|November 8, 2021
Autoimmune and inflammatory manifestations associated with acute myeloid leukemia with Trisomy 8-Case series and review of the literatureShira Buchrits, Dror Kozlovoski, Anat Gafter-Gvili, et al.
The Cochrane Database of Systematic Reviews|June 15, 2012
Colony-stimulating factors for prevention and treatment of infectious complications in patients with acute myelogenous leukemiaRonit Gurion, Yulia Belnik-Plitman, Anat Gafter-Gvili, et al.
Acta Haematologica|February 1, 2023
A Longitudinal Assessment of the Natural Change in Haemoglobin, Haematocrit, and Mean Corpuscular Volume with AgeIdan Goldberg, Eytan Cohen, Anat Gafter-Gvili, et al.
Acta Haematologica|November 25, 2024
Coronary Artery Disease and Microvascular Ischemia in Patients with Cardiac AmyloidosisOsnat Itzhaki Ben Zadok, Iuliana Vaxman, Sara Hoss, et al.
The Israel Medical Association Journal : IMAJ|June 24, 2009
Surveillance of infectious complications in hemato-oncological patientsRon Ram, Anat Gafter-Gvili, Pia Raanani, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 11, 2022
Outcomes of neutropenic hemato-oncological patients with viridans group streptococci (VGS) bloodstream infection based on penicillin susceptibilityLiat Shargian, Mical Paul, Tal Nachshon, et al.
Leukemia & Lymphoma|July 21, 2021
Late onset neutropenia after rituximab and obinutuzumab treatment - characteristics of a class-effect toxicityShai Shimony, Einat Bar-Sever, Tamar Berger, et al.
Cell Cycle (Georgetown, Tex.)|March 16, 2007
Apaf1 in chronic myelogenous leukemia (CML) progression: reduced Apaf1 expression is correlated with a H179R p53 mutation during clinical blast crisisOsnat Ashur-Fabian, Konstantin Adamsky, Luba Trakhtenbrot, et al.
Pageof 28